Helicobacter pylori and type 2 diabetes mellitus. Negative results and goals of future studies

Saudi Medical Journal

Volumn 29, Issue 8, 2008, Pages 1213-

  Pellicano, Rinaldo ^a   Astegiano, Marco ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ANALYTICAL ERROR; DIET RESTRICTION; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSULIN RESISTANCE; LETTER; MEDICAL RESEARCH; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; SAMPLE SIZE; SEROPREVALENCE; TREATMENT OUTCOME; CHRONIC DISEASE; NOTE;

CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 56149120449     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Gasbarrini A, Carloni E, Gasbarrini G, Chisholm SA. Helicobacter pylori and extragastric diseases- other Helicobacters. Helicobacter 2004; 9 (Supp 1): I57-I66.
2. Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996; 41: 458-461.
3. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039-1046.
4. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005; 28: 214-217.
5. Lo MK, Lee KF, Chan NN, Leung WY, Ko GT, Chan WB, et al. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy. Diabetes Obes Metab 2004; 6: 223-230.
6. Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G et al. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005; 50: 2090-2093.
7. Avogaro A. Insulin resistance: Trigger or concomitant factor in the metabolic syndrome. Panmin-erva Med 2006; 48: 3-12.
8. de Luis DA, Cordero JM, Caballero C, Boixeda D, Aller R, Canton R, et al. Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2001; 52: 1-9.
9. Moghimi J, Toussy J, Babaei M, Mousavi S, Tamadon M, Karamai M. Effect of Helicobacter pylori eradication on short-term control of glycemia in patients with type 2 diabetes mellitus. Saudi Med J 2007; 28: 475-476.
10. Schulz KF, Grimes DA. Sample size calculations in randomized trials: mandatory and mystical. Lancet 2005; 365: 1348-53.